Skip to content

Investigation of the Efficacy and Mechanism of Stroke No. 2 prescription in the Treatment of Ischemic Stroke Based on Neurovascular Unit Homeostasis

Investigation of the Efficacy and Mechanism of Stroke No. 2 prescription in the Treatment of Ischemic Stroke Based on Neurovascular Unit Homeostasis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002303
Enrollment
Unknown
Registered
2025-11-21
Start date
2024-09-06
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ischemic stroke

Interventions

Conventional treatment combined with Stroke No. 2 prescription group:In addition to the above conventional treatment, the medication group was treated with oral administration of Stroke No. 2 formula
Conventional treatment group:The conventional treatment group will receive antiplatelet therapy (Aspirin Enteric-coated Tablets: 100 mg once daily) lipid-lowering and plaque-stabilizing treatment (Ato

Sponsors

Maanshan City Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Meets the diagnostic criteria of both traditional Chinese medicine (TCM) and Western medicine; 2) Aged between 40 and 75 years with a disease duration ranging from 2 weeks to 3 months; 3) First-ever onset of consciousness without severe cognitive impairment and capable of following motor instructions; 4) The patient has voluntarily consented to participate in this study.

Exclusion criteria

Exclusion criteria: 1) The diagnostic criteria and inclusion criteria of Chinese and Western medicine were not met; 2) with severe mental retardation, aphasia, and communication disorder; 3) Complicated with serious medical diseases of the heart, liver, lung, kidney and other vital organs; 4) Hand dysfunction caused by rheumatoid arthritis, peripheral nerve injury and other causes; 5) Patients received other related treatments within 3 months before the study, which may affect the evaluation of the efficacy of the study; 6) Skin sensitivity, bleeding tendency and acute suppurative inflammation are unsuitable for acupuncture.

Design outcomes

Primary

MeasureTime frame
National Institutes of Health Stroke Scale (NIHSS) score;Traditional Chinese Medicine (TCM) Syndrome Score;

Secondary

MeasureTime frame
Assessment of Activities of Daily Living ;Fugl-Meyer Assessment (FMA);

Countries

China

Contacts

Public ContactFang Ying

Maanshan City Traditional Chinese Medicine Hospital

ffyysly@163.com+86 186 5553 6883

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026